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Chronic kidney disease (CKD) is a condition in which the kidneys are damaged or cannot filter blood as 
well as healthy kidneys. Because of this, excess fluid and waste from the blood remain in the body and 
may cause other health problems.
CKD Is Common Among Adults in the United States
Fast Stats
 • 30 million people or 15% of US adults are estimated to 
have CKD.*
 • 48% of those with severely reduced kidney function 
but not on dialysis are not aware of having CKD. 
 • Most (96%) people with kidney damage or mildly 
reduced kidney function are not aware of having CKD.
Risk Factors for Developing CKD
Adults with diabetes, high blood pressure, or both have a higher risk of developing CKD than 
those without these diseases. Other risk factors for CKD include heart disease, obesity, and a 
family history of CKD. 
 • CKD is estimated to be more common in 
women than in men (16% vs 13%).* 
 • CKD is also estimated to be more common 
in non-Hispanic blacks than in non-Hispanic 
whites (18% vs 13%).* 
 • 15% of Hispanics are estimated to have CKD.*
Keep your kidneys healthy 
by controlling your blood 
sugar and blood pressure.
Prevalence* of CKD Among US Adults Aged 
18 Years or Older, By Sex and Race/Ethnicity
*Prevalence (percentage) of CKD stages 1–5 among US adults aged 18 years or older using data from the 2011–2014 National Health and 
Nutrition Examination Survey and the CKD Epidemiology Collaboration (CKD-EPI) equation. These estimates are subject to variability and do 
not account for persistence of albuminuria or creatinine as indicated by the Kidney Disease Improving Global Outcomes recommendations. 
Estimates by sex, race, or ethnicity were age-adjusted using the 2000 US standard population.
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Reported Causes of New Cases of ESRD  
in the United States
Symptoms, Testing, and Treatment
 • People with CKD may not feel ill or notice any symptoms. The only way to find out for sure if you have CKD is 
through specific blood and urine tests. These tests include measurement of both the creatinine level in the blood 
and protein in the urine.
 • Once detected, CKD may be addressed through lifestyle changes, including making healthier choices about what 
you eat and drink, and can often be treated with medications. These approaches and treatments may keep CKD from 
getting worse and may prevent additional health problems such as heart disease. 
 • People with diabetes or high blood pressure who are diagnosed with CKD should talk to their doctor about treating 
these conditions to keep their blood sugar and blood pressure under control and lower their risk for kidney failure. 
Health Problems Caused and 
Affected by CKD
Kidney Failure
 • Kidney disease usually gets worse over time 
though treatment has been shown to slow 
progression. When the kidneys stop working, 
dialysis or kidney transplant is needed for 
survival. Kidney failure treated with dialysis 
or kidney transplant is called end-stage renal 
disease (ESRD). Not all patients with kidney 
disease progress to kidney failure and, in some 
patients, kidney disease progresses to kidney 
failure even with proper treatment. 
Renal is a medical term 
meaning “having to do with  
the kidneys.”
Some Facts About ESRD
 • In 2014, 118,000 people in the United States started 
treatment for ESRD, and 662,000 were living on 
chronic dialysis or with a kidney transplant. 
 • Men are 64% more likely than women to 
develop ESRD.
 • African Americans are 3 times more likely than 
whites to develop ESRD. 
 • Hispanics are 35% more likely than non-
Hispanics to develop ESRD.  
 • In US adults aged 18 years or older, the main 
reported causes of new cases of ESRD are 
diabetes and high blood pressure.
 • In US adolescents aged 13 to 17 years, the 
main reported cause of new cases of ESRD is 
glomerulonephritis (inflammation of the kidneys). 
N=118,014 (all ages, 2014)
Source: US Renal Data System
*Includes glomerulonephritis and cystic kidney disease, among other causes.
Heart Disease and Stroke
 • Having kidney disease increases the chances of also having 
heart disease and stroke.
 • Managing blood pressure, blood sugar, and cholesterol 
levels—all risk factors for heart disease and stroke—is more 
difficult, but much more important in the presence of CKD. 
Other Health Consequences of CKD
 • Anemia or low number of red blood cells can cause fatigue 
and weakness. 
 • Infections can occur because of a weakened immune system. 
 • Low calcium levels and high phosphorus levels in the blood 
can cause bone problems.  
 • High potassium levels in the blood (hyperkalemia) can 
cause an irregular or abnormal heartbeat.
 • Loss of appetite or eating less.
 • Excess fluids in the body causing high blood pressure, swelling 
in the legs, or shortness of breath because of fluid in the lungs (a 
condition known as pulmonary edema). 
 • Depression or lower quality of life.
Risk of Dying 
Premature death from both heart disease and from all causes is 
higher in adults with CKD compared with adults without CKD.  
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Opportunities to Prevent CKD and 
Lower the Risk for Kidney Failure
 • Control risk factors for CKD that can be 
modified.
 – High blood pressure.
 – High blood sugar levels. 
 • Test for kidney disease among people who are 
at high risk for developing CKD. 
 – Testing people with diabetes or with high 
blood pressure has been shown to be a 
cost-effective way of identifying people 
with CKD.  
 • Manage CKD.
 – Make lifestyle changes (e.g., healthy eating) 
to prevent more kidney damage.
 – Use medications (e.g., drugs to lower blood 
pressure) to slow CKD progression.
 – Avoid conditions or exposures that can 
harm the kidneys or cause a sudden drop in 
kidney function (called acute kidney injury) 
and may quicken CKD progression. 
• Kidney infections.
• Medications. 
  Over-the-counter pain medicines like 
ibuprofen and naproxen.  
  Certain antibiotics. 
• Herbal supplements.
• Dyes that are used to make the blood 
vessels or organs visible on X-rays or other 
imaging tests.
 • Learn about kidney disease from your health 
care team to make sure your treatment is 
optimal and also to help improve outcomes 
after beginning ESRD treatment.
Page 4 of 4
References
1. Centers for Disease Control and Prevention. Chronic kidney 
disease surveillance system website. http://www.cdc.gov/ckd. 
Accessed March 9, 2017.
2. Kidney Disease: Improving Global Outcomes CKD Work Group. 
KDIGO 2012 clinical practice guideline for the evaluation and 
management of chronic kidney disease. Kidney Inter. 2013;3(1)
(suppl):1–150.  
3. Meisinger C, Döring A, Löwel H, KORA Study Group. Chronic 
kidney disease and risk of incident myocardial infarction and 
all-cause and cardiovascular disease mortality in middle-aged 
men and women from the general population. Eur Heart J. 
2006;27(10):1245–1250. 
4. National Institutes of Health. 2016 USRDS Annual Data Report: 
Epidemiology of Kidney Disease in the United States. Bethesda, MD: 
National Institutes of Health, National Institute of Diabetes and 
Digestive and Kidney Diseases;2016.  
5. Astor BC, Hallan SI, Miller ER 3rd, Yeung E, Coresh J. Glomerular 
filtration rate, albuminuria, and risk of cardiovascular and 
all-cause mortality in the U.S. population. Am J Epidemiol. 
2008;167(10):1226–1234.
6. Hemmelgarn BR, James MT, Manns BJ, et al. Rates of treated 
and untreated kidney failure in older vs younger adults. JAMA. 
2012;307(23):2507–2715.
7. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic 
kidney disease and the risks of death, cardiovascular events, and 
hospitalization. N Engl J Med. 2004;351(13):1296–1305.
8. Perlman RL, Finkelstein FO, Liu L, et al. Quality of life in chronic 
kidney disease (CKD): a cross-sectional analysis in the Renal 
Research Institute-CKD study. Am J Kidney Dis. 2005;45(4):658–
666.
9. Kinchen KS, Sadler J, Fink N, et al. The timing of specialist 
evaluation in chronic kidney disease and mortality. Ann Intern 
Med. 2002;17;137(6):479–486. 
10. Vassalotti JA, Li S, Chen SC, Collins AJ. Screening populations 
at increased risk of CKD: the Kidney Early Evaluation Program 
(KEEP) and the public health problem. Am J Kidney Dis. 
2009;53(3suppl3):S107–S114. 
11. Snyder JJ, Collins AJ. Association of preventive health care with 
atherosclerotic heart disease and mortality in CKD. J Am Soc 
Nephrol. 2009;20(7):1614–1622. 
12. Hoerger TJ, Wittenborn JS, Segel JE, et al.  A health policy model 
of CKD: 2. The cost-effectiveness of microalbuminuria screening. 
Am J Kidney Dis. 2010;55(3):463–473. 
13. Hoerger TJ, Wittenborn J, Zhuo X, et al. Cost-effectiveness of 
screening for microalbuminuria among African Americans. J Am 
Soc Nephrol. 2012;23(12):2035–2041.
Acknowledgments
The following organizations* collaborated in developing and 
reviewing this fact sheet:
 • Centers for Disease Control and Prevention  
http://www.cdc.gov/ckd
 • Centers for Medicare and Medicaid Services  
http://cms.hhs.gov/
 • US Department of Defense http://www.health.mil/
 • US Department of Veterans Affairs  
http://www.va.gov/health





 • National Heart Lung and Blood Institute of the National 
Institutes of Health http://www.nhlbi.nih.gov/
 • National Institute of Diabetes and Digestive and Kidney 
Diseases of the National Institutes of Health  
http://www.niddk.nih.gov/
 • National Kidney Disease Education Program  
http://www.nkdep.nih.gov/
 • American Society of Nephrology http://www.asn-online.org/
 • National Kidney Foundation http://www.kidney.org/
 • United States Renal Data System https://www.usrds.org/
 • University of California, San Francisco, and University of 
California, San Francisco Center for Vulnerable Populations 
http://www.ucsf.edu/
 • University of Michigan, Division of Nephrology, Department 
of Internal Medicine, and University of Michigan Kidney 
Epidemiology and Cost Center  http://www.med.umich.edu/
intmed/nephrology/For Public Inquiries and Publications 




In English and Spanish 24 hours a day, 7 days a week
For Other Information
Division of Diabetes Translation
National Center for Chronic Disease Prevention and 
Health Promotion
Centers for Disease Control and Prevention
4770 Buford Highway NE, Mailstop F-75 
Atlanta, GA 30341-3717
Telephone 770-488-5000; Fax 770-488-8211 
*Links to nonfederal organizations are provided solely as a service to our users. Links do 
not constitute an endorsement of any organization by CDC or the federal government, 
and none should be inferred.  CDC is not responsible for the content of the individual 
organization web pages found at this link.
 Note
This publication is not subject to copyright restrictions. 
Please duplicate and distribute copies as desired. 
Suggested Citation
Centers for Disease Control and Prevention. National 
Chronic Kidney Disease Fact Sheet, 2017. Atlanta, GA:  
US Department of Health and Human Services,  
Centers for Disease Control and Prevention; 2017.
